Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

CUSIP: 59935V107

Q4 2025 13F Holders as of 31 Dec 2025

Security identity
Security type / class
Equity / Common Shares, no par value per share
Shares outstanding
124,817,707
Holder snapshot
Total 13F shares
26,494,301
Share change
-7,634,652
Total reported value
$53,565,472
Put/Call ratio
517%
Reported price per share
$2.02
Number of holders
79
Value change
-$15,312,984
Number of buys
47
Number of sells
18

Security key

59935V107

Report period

Q4 2025

Institutions

79

Top holders

10

MIST full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Milestone Pharmaceuticals Inc. SEC filings Milestone Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Propel Bio Management, LLC
13D/G signal
Propel Bio Management, LLC
Evidence rows
15
Latest as of
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: Propel Bio Management, LLC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Propel Bio Management, LLC
13D/G 13F
Company
13D/G 13F
9.9%
$21,001,011
8,861,186 shares
 $0 11 Jul 2025
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
13D/G
0.6%
$396,161
322,082 shares
 $0 31 Mar 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
5.6%
$13,952,000
6,976,000 shares
 — 30 Sep 2025
ORBIMED ADVISORS LLC
13F
Company
13F
2.6%
$6,443,656
3,221,828 shares
 — 30 Sep 2025
MORGAN STANLEY
13F
Company
13F
2.4%
$5,938,134
2,969,067 shares
 — 30 Sep 2025
Simplify Asset Management Inc.
13F
Company
13F
2.3%
$5,665,948
2,832,974 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
79
Shares
26,494,301
Rows available
79
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
61
Q4 2025 holders
79
Holder diff
18
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .